Teligene
PrivateLast Round
Series C
Feb 22, 2021
Total Funding Raised
$103.49M
Company Overview
Teligene is a biotechnology company that develops small-molecule targeted innovative drugs for the treatment of various types of cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teligene Comparables
Compare Teligene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen TargetRx | 86% | |
| Shengke Pharmaceuticals (Jiangsu) Ltd. | 83% | |
| Suzhou Genhouse Bio Co., Ltd. | 83% |
Teligene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 22, 2021 | ||||
| Series A | Jul 6, 2017 |
Teligene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series C |
| IDG Capital | Series C |
| Mirae Asset | Series C |
| China International Capital Corporation | Series C |
| Hankang Capital | Series A |
| Shenzhen Capital Group | Series A |
Teligene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Teligene's valuation, stock price, and market status.
Is Teligene a public or private company?
Teligene is a private company.
What is the current stock price of Teligene?
Teligene is a private company with no public stock price. No recent secondary market data is available.
How much is Teligene worth (valuation)?
Valuation information for Teligene is not publicly available.
Can I buy Teligene stock?
Teligene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Teligene's last funding round?
Teligene's most recent funding round was Series C on February 22, 2021.
Who are the main investors in Teligene?
Key investors in Teligene include Hankang Capital.
Will Teligene IPO soon?
No public IPO plans have been announced for Teligene.
How can I track Teligene secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Teligene's secondary market activity and sign up for updates.